XTAG CYP2C19 KIT V3

Drug Metabolizing Enzyme Genotyping Systems

LUMINEX MOLECULAR DIAGNOSTICS, INC.

The following data is part of a premarket notification filed by Luminex Molecular Diagnostics, Inc. with the FDA for Xtag Cyp2c19 Kit V3.

Pre-market Notification Details

Device IDK131565
510k NumberK131565
Device Name:XTAG CYP2C19 KIT V3
ClassificationDrug Metabolizing Enzyme Genotyping Systems
Applicant LUMINEX MOLECULAR DIAGNOSTICS, INC. 439 UNIVERSITY AVE. Toronto, Ontario,  CA M5g 1y8
ContactRonald Dunn
CorrespondentRonald Dunn
LUMINEX MOLECULAR DIAGNOSTICS, INC. 439 UNIVERSITY AVE. Toronto, Ontario,  CA M5g 1y8
Product CodeNTI  
CFR Regulation Number862.3360 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2013-05-30
Decision Date2013-09-11

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00840487100172 K131565 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.